Key Points
- Christophe Mossé appointed as CEO of Arkopharma group
- He will oversee Arkopharma’s activities and related activities of Dermapharm Group.
- Brings industry expertise from leading groups: Naos, Galderma, Novartis,…
Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements.
Arkopharma, a European leader in its field, has announced the arrival of Christophe Mossé as CEO (cf. LinkedIn post below)
Christophe Mossé brings a wealth of experience in the pharmaceutical industry, both in France and internationally.
With his expertise, Christophe Mossé will lead Arkopharma’s activities and related operations of Dermapharm Group, and will be the main link between the management teams of the two entities.
Arkopharma is now present in more than 60 countries and is positioned as the European leader in phytotherapy medicines and dietary supplements.
With 1,212 employees and a consolidated turnover of 201 million euros, Arkopharma dedicates 8.5% of its workforce to research and development, with 1,635 registrations and marketing authorizations for medicines.
Health Nice Côte d’Azur
- Unlocking Life Sciences Opportunities in the South of France
- Pasteur 2: A Strategic Expansion for the Nice University Hospital and Healthcare Innovation
- Arab Health 2025: Team Nice Côte d’Azur showcases the health ecosystem of the Nice Côte d’Azur Metropolis
- algenScribe Secures Refinancing to Accelerate Its Technological Development
- CHU Nice and Université Côte d’Azur strengthen their international cooperation with Beirut.
- The Association of Veterinary Consultants (AVC): Connecting Nice to a Global Network
- The Skin Institute to Be Established in Nice
- The Métropole Nice Côte d’Azur Propels Its Startups to CES Las Vegas 2025
- Virbac announces changes in its executive management
- Virbac finalizes acquisition of minority stake in Globion, Indian poultry vaccine specialist.
